Form 8-K AUXILIUM PHARMACEUTICALS For: Sep 10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Auxilium's (AUXL) Restructuring Seen as Positive by MKM
September 10, 2014 11:44 AM EDTMKM affirms Auxilium (Nasdaq; AUXL) at Buy with a price target of $26 following news that the company plans to reduce annual expenses by at least $75 million and headcount by 30 percent.
MKM noted the following key points:Auxilium's merger with QLT is expected to close by October 31, will significantly... More
